DonitriptanAlternative Names: F 11356
Latest Information Update: 22 May 2000
At a glance
- Originator Pierre Fabre
- Class Antimigraines; Nitriles; Piperazines; Small molecules; Tryptamines
- Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 22 May 2000 INN approved name for F 11356 is donitriptan
- 12 May 1999 Discontinued-Preclinical for Migraine in France (PO)
- 29 Dec 1998 New profile